Syndax Pharmaceuticals Inc Annual Interest Expense in USD from 2020 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Syndax Pharmaceuticals Inc quarterly/annual Interest Expense history and growth rate from 2020 to 2023.
  • Syndax Pharmaceuticals Inc Interest Expense for the quarter ending June 30, 2024 was $45K, a 28.6% increase year-over-year.
  • Syndax Pharmaceuticals Inc Interest Expense for the twelve months ending June 30, 2024 was $233K, a 87.5% decline year-over-year.
  • Syndax Pharmaceuticals Inc annual Interest Expense for 2023 was $208K, a 93.4% decline from 2022.
  • Syndax Pharmaceuticals Inc annual Interest Expense for 2022 was $3.14M, a 65.2% increase from 2021.
  • Syndax Pharmaceuticals Inc annual Interest Expense for 2021 was $1.9M, a 19.4% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $208K -$2.93M -93.4% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $3.14M +$1.24M +65.2% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $1.9M -$458K -19.4% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-27
2020 $2.36M Jan 1, 2020 Dec 31, 2020 10-K 2023-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.